IPP Bureau
Switzerland grants conditional marketing authorisation for Novavax Covid-19 vaccine
By IPP Bureau - April 13, 2022
Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Switzerland
Wacker, CordenPharma to produce mRNA vaccines for Germany
By IPP Bureau - April 12, 2022
Both companies have been selected for stand-by production by German government
One-dose HPV vaccine offers solid protection against cervical cancer
By IPP Bureau - April 12, 2022
This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls
Jorge Gomez joins Moderna as Chief Financial Officer
By IPP Bureau - April 12, 2022
Gomez joins Moderna from Dentsply Sirona, where he served as Executive Vice President & Chief Financial Officer since August 2019
Carestream installs DRX Compass at Gati Diagnostic Centre
By IPP Bureau - April 12, 2022
The DRX-Compass helps navigate and accelerate towards superb performance with a solution that grows with its customers
PhableCare raises Rs 187 crore in Series B funding
By IPP Bureau - April 12, 2022
The funding round is led by Kalaari Capital. Aflac Ventures, Digital Horizon, Stride Ventures, and existing investors also participated in the round
Dr. Morepen launches advanced muscle food
By IPP Bureau - April 12, 2022
Ideal power boosters to strengthen muscles and keep energised for all kinds of physical activities
Aleor receives USFDA approval for Lidocaine and Prilocaine Cream
By IPP Bureau - April 12, 2022
Lidocaine and Prilocaine Cream USP, 2.5%/2.5% has an estimated market size of US $ 29 million for twelve months ending Dec. 2021 according to IQVIA
Pharmapack Europe 2022 to open on May 18-19 in Paris
By IPP Bureau - April 12, 2022
Pharmapack trends are a key barometer of global device and packing opportunities in 2022
Thermo Fisher Scientific deploys cryo-transmission electron microscope at CCMB, Hyderabad
By IPP Bureau - April 12, 2022
It supports advanced research and helps scientists accelerate potential cures, drug discoveries and diagnostics research
Healthcare Venture’s Wavemaker360 appoints Monica Jain as new partner
By IPP Bureau - April 12, 2022
Cedars-Sinai Medical Center Surgeon and Surgical Innovation Officer Dr. Jain joins the venture fund to bring clinical expertise to a portfolio of budding seed-stage healthcare companies
ReiThera and Exothera collaborate to develop large-scale, low cost per dose vaccine
By IPP Bureau - April 12, 2022
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
Cambrex completes large-scale US API expansion
By IPP Bureau - April 12, 2022
The expansion positions Cambrex with the largest and most advanced API facility in the United States
New very-high-sensitivity rapid antigen test kits hit Australian market
By IPP Bureau - April 11, 2022
New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia
Glenmark Specialty receives DCGI approval for Phase 1 clinical trial of its novel molecule
By IPP Bureau - April 11, 2022
GRC 54276 has shown tumour cell killing ability in preclinical studies as a single agent and as well in combination with checkpoint inhibitors, making it a high-priority target in immuno-oncology
